Get started
leopisbig

Viridian Therapeutics entered mark up phase

Long
Viridian Therapeutics, Inc. (NASDAQ:VRDN)  
leopisbig  
NASDAQ:VRDN   Viridian Therapeutics, Inc.
Trend Lines Supply and Demand VRDN
0
0
trendline supplyanddemand vrdn
VRDN has been in an accumulation phase since 2020.

Moreover, the price has recently moved above EMAs (10, 21 and 30) with price gap and significant volume increase.

I think price will continue its mark up phase in the next days.

IMPORTANT: This is not financial advice.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.